Skip to main content
Loading market data...
ETF NYSE Arca USD

Invesco Pharmaceuticals ETF PJP

Issuer: Invesco SEC registrant: Invesco Exchange-Traded Fund Trust Equity · US
Watch PJP (sign in) Add to portfolio (PJP) Set an alert for PJP Compare PJP with other ETFs Position size calculator for PJP at 126.41 USD

How position sizing works
Last price 126.41 USD Change: Up +2.89 Percent change: Up +2.34%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.57%
Prospectus 28 Aug 2025
Net assets
$472.1M
As of 31 Jul 2026
Holdings
33
As of 31 Jul 2026
12-month distribution yield
0.89%
Quarterly
Asset class
Equity
From holdings

Invesco Pharmaceuticals ETF (PJP) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Invesco. Its category is Equity · US (equity). Its last price was US$126.41 on 20 Oct 2026. Its expense ratio is 0.57% a year, from its prospectus dated 28 Aug 2025. It reported net assets of US$472.1 million as of 31 Jul 2026. Its latest holdings report lists 33 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$1.13 a unit, a 12-month distribution yield of 0.89%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.57%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.50%
Prospectus date
28 Aug 2025
Filed with the SEC
27 Aug 2025

Source: SEC prospectus risk/return data sets (opens in a new tab) Filed

Size and reporting

Net assets
$472,102,031
Total assets
$527,662,978
Holdings as of
31 Jul 2026
Report made public
28 Sep 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Source: SEC Form N-PORT (opens in a new tab) Filed

Top holdings

Largest 25 of 33 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

PJP top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Invesco Private Prime Fund No identifier reported 7.93% $37.4M Short-term investment vehicles (cash funds) United States USD
2 Abbott Laboratories US0028241000 5.67% $26.8M Equity (common) United States USD
3 AbbVie Inc. US00287Y1091 5.48% $25.9M Equity (common) United States USD
4 Amgen Inc. US0311621009 5.33% $25.2M Equity (common) United States USD
5 Johnson & Johnson US4781601046 5.18% $24.4M Equity (common) United States USD
6 Merck & Co., Inc. US58933Y1055 5.06% $23.9M Equity (common) United States USD
7 Eli Lilly and Co. US5324571083 5.02% $23.7M Equity (common) United States USD
8 Corcept Therapeutics Inc. US2183521028 4.96% $23.4M Equity (common) United States USD
9 Gilead Sciences, Inc. US3755581036 4.53% $21.4M Equity (common) United States USD
10 Pfizer Inc. US7170811035 4.50% $21.2M Equity (common) United States USD
11 Amneal Pharmaceuticals, Inc. US03168L1052 3.75% $17.7M Equity (common) United States USD
12 Invesco Private Government Fund No identifier reported 3.73% $17.6M Short-term investment vehicles (cash funds) United States USD
13 Liquidia Corp. US53635D2027 3.66% $17.3M Equity (common) United States USD
14 Travere Therapeutics, Inc. US89422G1076 3.30% $15.6M Equity (common) United States USD
15 Ligand Pharmaceuticals Inc. US53220K5048 3.20% $15.1M Equity (common) United States USD
16 Regeneron Pharmaceuticals, Inc. US75886F1075 3.14% $14.8M Equity (common) United States USD
17 Harmony Biosciences Holdings, Inc. US4131971040 3.06% $14.5M Equity (common) United States USD
18 Bristol-Myers Squibb Co. US1101221083 2.94% $13.9M Equity (common) United States USD
19 Viatris Inc. US92556V1061 2.83% $13.3M Equity (common) United States USD
20 Jazz Pharmaceuticals PLC IE00B4Q5ZN47 2.79% $13.2M Equity (common) Ireland USD
21 Biogen Inc. US09062X1037 2.75% $13.0M Equity (common) United States USD
22 Collegium Pharmaceutical, Inc. US19459J1043 2.74% $12.9M Equity (common) United States USD
23 Prestige Consumer Healthcare Inc. US74112D1019 2.74% $12.9M Equity (common) United States USD
24 Ocular Therapeutix, Inc. US67576A1007 2.58% $12.2M Equity (common) United States USD
25 ANI Pharmaceuticals, Inc. US00182C1036 2.55% $12.0M Equity (common) United States USD

Source: SEC Form N-PORT (opens in a new tab) Made public Holdings as of 31 Jul 2026

All 33 stored holdings

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.92%
Short-term investment vehicles (cash funds) 11.76%

Country

Country by weight
CountryWeightBar
United States 106.45%
Ireland 5.24%

The country each issuer is assigned to in the report.

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 111.69%

The currency each holding is denominated in. Currency hedges are not netted off, so a hedged fund still shows its holdings' currencies.

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 79.67%

Partial coverage: sectors are known for 79.7% of net assets (80% of the fund's equity weight), the holdings matched by CUSIP or ticker to US stocks listed on this site. The rest is not assigned a sector.

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$1.1290
4 payments per unit
12-month yield
0.89%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
21 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($1.1290) ÷ latest price ($126.41) × 100 = 0.89%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (20 payments)
PJP distributions per unit by ex-date
Ex-dateAmount per unit
21 Sep 2026$0.3010
22 Jun 2026$0.2730
23 Mar 2026$0.3090
22 Dec 2025$0.2460
22 Sep 2025$0.2360
23 Jun 2025$0.2670
24 Mar 2025$0.2730
23 Dec 2024$0.2230
23 Sep 2024$0.2000
24 Jun 2024$0.2100
18 Mar 2024$0.1700
18 Dec 2023$0.1910
18 Sep 2023$0.2010
20 Jun 2023$0.1760
20 Mar 2023$0.2020
19 Dec 2022$0.1680
19 Sep 2022$0.1690
21 Jun 2022$0.2070
21 Mar 2022$0.2020
20 Dec 2021$0.1850

Source: Yahoo Finance (opens in a new tab) Checked · 2 days ago Amounts are adjusted for later unit splits

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources
    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Region and currency: automatic

    Prices stay in each listing's own currency. Your currency is used for totals and for "≈" estimates at the daily reference rate. How this works

    Colour theme